These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. GSDMD KNOCKOUT ALLEVIATES SEPSIS-ASSOCIATED SKELETAL MUSCLE ATROPHY BY INHIBITING IL18/AMPK SIGNALING. Zhang Y; Li T; Liu Y; Wang C; Wang D; Xu L; Zhao H; Bai X; Li Z; Wang Y Shock; 2024 Oct; 62(4):565-573. PubMed ID: 39227368 [TBL] [Abstract][Full Text] [Related]
5. [Diagnostic accuracy of muscle ultrasound and plasma monocyte chemoattractant protein-1 for ICU-acquired weakness in patients with sepsis]. Ding M; Ren S; Dong X; Wang X; Zhao X; Qin B Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jan; 34(1):12-17. PubMed ID: 35307054 [TBL] [Abstract][Full Text] [Related]
6. Neuronal-Activated ILC2s Promote IL-17A Production in Lung γδ T Cells During Sepsis. Chen W; Lai D; Li Y; Wang X; Pan Y; Fang X; Fan J; Shu Q Front Immunol; 2021; 12():670676. PubMed ID: 33995408 [TBL] [Abstract][Full Text] [Related]
7. Sepsis Induces Deregulation of IL-13 Production and PD-1 Expression in Lung Group 2 Innate Lymphoid Cells. Akama Y; Park EJ; Satoh-Takayama N; Gaowa A; Ito A; Kawamoto E; Darkwah S; Appiah MG; Myint PK; Ohno H; Imai H; Shimaoka M Shock; 2021 Mar; 55(3):357-370. PubMed ID: 32826811 [TBL] [Abstract][Full Text] [Related]
8. Assessment of intensive care unit-acquired weakness in young and old mice: An E. coli septic peritonitis model. Witteveen E; Hoogland IC; Wieske L; Weber NC; Verhamme C; Schultz MJ; van Schaik IN; Horn J Muscle Nerve; 2016 Jan; 53(1):127-33. PubMed ID: 26015329 [TBL] [Abstract][Full Text] [Related]
9. Adipose tissue protects against sepsis-induced muscle weakness in mice: from lipolysis to ketones. Goossens C; Weckx R; Derde S; Dufour T; Vander Perre S; Pauwels L; Thiessen SE; Van Veldhoven PP; Van den Berghe G; Langouche L Crit Care; 2019 Jul; 23(1):236. PubMed ID: 31262340 [TBL] [Abstract][Full Text] [Related]
10. Hydrocortisone mitigates ICU-AW by fine-tuning of muscle atrophic and hypertrophic signaling pathways in a sepsis model with limb immobilization. Habr B; Saliba Y; Hajal J; Smayra V; Riachy M; Fares N Life Sci; 2020 Nov; 261():118366. PubMed ID: 32871182 [TBL] [Abstract][Full Text] [Related]
11. Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis. Wang F; Huang X; Chung CS; Chen Y; Hutchins NA; Ayala A Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G237-45. PubMed ID: 27288425 [TBL] [Abstract][Full Text] [Related]
12. Skeletal Muscle Index at Intensive Care Unit Admission Is a Predictor of Intensive Care Unit-Acquired Weakness in Patients With Sepsis. Mitobe Y; Morishita S; Ohashi K; Sakai S; Uchiyama M; Abeywickrama H; Yamada E; Kikuchi Y; Nitta M; Honda T; Endoh H; Kimura S; Sakano S; Koyama Y J Clin Med Res; 2019 Dec; 11(12):834-841. PubMed ID: 31803328 [TBL] [Abstract][Full Text] [Related]
13. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the NLRP3/IL-1β axis protects against sepsis-induced cardiomyopathy. Busch K; Kny M; Huang N; Klassert TE; Stock M; Hahn A; Graeger S; Todiras M; Schmidt S; Chamling B; Willenbrock M; Groß S; Biedenweg D; Heuser A; Scheidereit C; Butter C; Felix SB; Otto O; Luft FC; Slevogt H; Fielitz J J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1653-1668. PubMed ID: 34472725 [TBL] [Abstract][Full Text] [Related]
15. PD-1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator-activated receptor-γ. Batyrova B; Luwaert F; Maravelia P; Miyabayashi Y; Vashist N; Stark JM; Soori SY; Tibbitt CA; Riese P; Coquet JM; Chambers BJ Immun Inflamm Dis; 2020 Mar; 8(1):8-23. PubMed ID: 31742928 [TBL] [Abstract][Full Text] [Related]
16. Intensive care unit-acquired weakness: unanswered questions and targets for future research. Piva S; Fagoni N; Latronico N F1000Res; 2019; 8():. PubMed ID: 31069055 [TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A1 mediates myotube atrophy via Toll-like receptors. Hahn A; Kny M; Pablo-Tortola C; Todiras M; Willenbrock M; Schmidt S; Schmoeckel K; Jorde I; Nowak M; Jarosch E; Sommer T; Bröker BM; Felix SB; Scheidereit C; Weber-Carstens S; Butter C; Luft FC; Fielitz J J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):103-119. PubMed ID: 31441598 [TBL] [Abstract][Full Text] [Related]
18. Muscle weakness in a Witteveen E; Wieske L; Manders E; Verhamme C; Ottenheijm CAC; Schultz MJ; van Schaik IN; Horn J Ann Transl Med; 2019 Jan; 7(1):9. PubMed ID: 30788356 [TBL] [Abstract][Full Text] [Related]
19. [Dynamic changes of diaphragm and limb skeletal muscle in patients with sepsis assessed by bedside ultrasound and their correlation with blood urea/creatinine ratio]. Ma J; Xia Y; Wang T; Chen J; Yang H; Ding H Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jun; 36(6):643-648. PubMed ID: 38991965 [TBL] [Abstract][Full Text] [Related]
20. Muscular Ultrasound, Syndecan-1 and Procalcitonin Serum Levels to Assess Intensive Care Unit-Acquired Weakness. Patejdl R; Walter U; Rosener S; Sauer M; Reuter DA; Ehler J Can J Neurol Sci; 2019 Mar; 46(2):234-242. PubMed ID: 30739614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]